Table 1 Examples of completed clinical trials evaluating the efficacy of probiotics or prebiotics in the treatment of COVID-19
Title | Interventions | Population | Locations | Clinical trial ID |
---|---|---|---|---|
Efficacy of Probiotics in Reducing Duration and Symptoms of COVID-19 | • Dietary supplement: probiotics (2 strains 10 × 109 UFC) • Dietary supplement: placebo (potato starch and magnesium stearate) | Enrollment: 17 | • CIUSSS de L’Estrie-CHUS Hospital, Sherbrooke, Quebec, Canada | NCT04621071 |
Study to Evaluate the Effect of a Probiotic in COVID-19 | • Dietary supplement: probiotic • Dietary supplement: placebo | Enrollment: 41 | • Hospital Universitario del Vinalopó, Elche, Alicante, Spain • Hospital Universitario de Torrevieja, Torrevieja, Alicante, Spain | NCT04390477 |
Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID-19 Infection | • Dietary supplement: probiotic • Dietary supplement: saline solution | Enrollment: 23 | • Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, Quebec, Canada | NCT04458519 |
The Effect of Probiotic Supplementation on SARS-CoV-2 Antibody Response After COVID-19 | • Dietary supplement: L. reuteri DSM 17938 + vitamin D • Dietary supplement: placebo + vitamin D | Enrollment: 161 | • Örebro University, Örebro, Örebro Län, Sweden | NCT04734886 |
Study to Investigate the Treatment Benefits of Probiotic Streptococcus Salivarius K12 for Hospitalized Patients (Non-ICU) With COVID-19 | • Drug: standard of care • Dietary supplement: BLIS K12 | Enrollment: 50 | • King Edward Medical University Teaching Hospital, Lahore, Punjab, Pakistan | NCT05043376 |
Oral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19 | • Combination product: oral probiotics • Other: oral placebo | Enrollment: 70 | • University of Passo Fundo, Passo Fundo, RS, Brazil | NCT05175833 |
Live Microbes to Boost Anti-Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Immunity Clinical Trial | • Dietary supplement: OL-1, standard dose • Dietary supplement: OL-1, high dose • Dietary supplement: placebo | Enrollment: 54 | • Rutgers University, New Brunswick, New Jersey, United States | NCT04847349 |
Efficacy of Probiotics in the Treatment of Hospitalized Patients With Novel Coronavirus Infection | • Dietary supplement: probiotic • Dietary supplement: placebo | Enrollment: 200 | • I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation | NCT04854941 |
Efficacy of L. plantarum and P. acidilactici in Adults With SARS-CoV-2 and COVID-19 | • Dietary supplement: probiotic • Dietary supplement: placebo | Enrollment: 300 | • Hospital General Dr. Manuel Gea Gonzalez, Mexico city, Mexico | NCT04517422 |
Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19 | • Dietary supplement: Lactobacillus rhamnosus GG • Dietary Supplement: Lactobacillus rhamnosus GG placebo | Enrollment: 182 | • Duke University, Durham, North Carolina, United States | NCT04399252 |
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III | • Dietary supplement: nutritional support system (NSS) • Other: conventional nutritional support designed by hospital nutritionists | Enrollment: 80 | • ISSEMYM “Arturo Montiel Rojas” Medical Center, Toluca de Lerdo, Mexico State, Mexico | NCT04507867 |